The Weekly Rebalance
Cannabis stocks look cheap—but the real reason might surprise you. 🌿📉 In this episode, we break down the massive tax burden (280E) that’s crushing profitability across the cannabis industry and why a potential shift from Schedule I to Schedule III could change everything. We also cover the broader market rebound, NASDAQ’s historic run, and why investors may be underestimating both opportunity and risk in cannabis equities. From rescheduling catalysts to competition from major players like pharma, this is a must-watch for anyone following emerging industries. 💬 Do you think cannabis stocks are undervalued—or a value trap? Comment below. 📲 Share this with a colleague or client who’s watching alternative asset trends. #Revisor #WeeklyRebalance #CannabisStocks #280E #RIATech #WealthManagementTech #InvestmentStrategy #MarketAnalysis #FinancialMarkets #AlternativeInvestments #EquityResearch #PortfolioStrategy #EmergingMarkets #Addepar #SingleIndexModel
37 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The Weekly Rebalance-Community!